Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Comi

Showing results (511-520 of 586) with videos related to

Pageof 59
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up studyS Mesaros, Ma Rocca, Mp Sormani, et al.
AJNR. American Journal of Neuroradiology|November 15, 2011
Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approachK Kacar, M A Rocca, M Copetti, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 13, 2011
White matter damage in frontotemporal lobar degeneration spectrumF Agosta, E Scola, E Canu, et al.
Acta Neurologica Scandinavica|April 11, 2017
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromesV Martinelli, G Dalla Costa, M J Messina, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyS Cook, P Vermersch, G Comi, et al.
Neurology|May 25, 2012
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trialM S Freedman, J S Wolinsky, B Wamil, et al.
The Pharmacogenomics Journal|December 9, 2015
Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosisF Clarelli, G Liberatore, M Sorosina, et al.
Neurology|July 30, 2008
The extracellular matrix affects axonal regeneration in peripheral neuropathiesS C Previtali, M C Malaguti, N Riva, et al.
Pageof 59

Showing results (511-520 of 586) with videos related to

Sort By:
Pageof 59
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up studyS Mesaros, Ma Rocca, Mp Sormani, et al.
AJNR. American Journal of Neuroradiology|November 15, 2011
Overcoming the clinical-MR imaging paradox of multiple sclerosis: MR imaging data assessed with a random forest approachK Kacar, M A Rocca, M Copetti, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 13, 2011
White matter damage in frontotemporal lobar degeneration spectrumF Agosta, E Scola, E Canu, et al.
Acta Neurologica Scandinavica|April 11, 2017
Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromesV Martinelli, G Dalla Costa, M J Messina, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 14, 2011
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) studyS Cook, P Vermersch, G Comi, et al.
Neurology|May 25, 2012
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trialM S Freedman, J S Wolinsky, B Wamil, et al.
The Pharmacogenomics Journal|December 9, 2015
Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosisF Clarelli, G Liberatore, M Sorosina, et al.
Neurology|July 30, 2008
The extracellular matrix affects axonal regeneration in peripheral neuropathiesS C Previtali, M C Malaguti, N Riva, et al.
Pageof 59